Clinuvel Pharmaceuticals (UR9) Financial Statements

0 Followers

Clinuvel Pharmaceuticals Financial Overview

Clinuvel Pharmaceuticals 's market cap is currently CHF239.84M. The company's EPS TTM is CHF0.68; its P/E ratio is 11.99; Clinuvel Pharmaceuticals is scheduled to report earnings on August 27, 2026, and the estimated EPS forecast is CHF0.15. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 26	Jun 25	Jun 24	Jun 23	Jun 22
Income Statement
Total Revenue	AU$ 94.02M	AU$ 95.02M	AU$ 88.18M	AU$ 78.32M	AU$ 65.72M
Gross Profit	AU$ 78.21M	AU$ 79.14M	AU$ 80.45M	AU$ 50.59M	AU$ 46.62M
Operating Income	AU$ 40.53M	AU$ 45.73M	AU$ 48.01M	AU$ 40.91M	AU$ 33.08M
EBITDA	AU$ 41.11M	AU$ 57.20M	AU$ 56.28M	AU$ 46.37M	AU$ 35.08M
Net Income	AU$ 33.92M	AU$ 36.17M	AU$ 35.64M	AU$ 30.60M	AU$ 20.88M
Balance Sheet
Cash & Short-Term Investments	AU$ 252.06M	AU$ 224.11M	AU$ 183.87M	AU$ 156.81M	AU$ 121.51M
Total Assets	AU$ 296.15M	AU$ 271.75M	AU$ 231.12M	AU$ 194.52M	AU$ 144.81M
Total Debt	AU$ 1.94M	AU$ 528.53K	AU$ 879.78K	AU$ 999.87K	AU$ 1.26M
Net Debt	AU$ -18.49M	AU$ -223.58M	AU$ -182.99M	AU$ -22.87M	AU$ -26.15M
Total Liabilities	AU$ 23.27M	AU$ 30.94M	AU$ 28.11M	AU$ 29.89M	AU$ 19.25M
Stockholders' Equity	AU$ 272.88M	AU$ 240.81M	AU$ 203.01M	AU$ 164.63M	AU$ 125.56M
Cash Flow
Free Cash Flow	AU$ 35.31M	AU$ 40.80M	AU$ 31.48M	AU$ 35.88M	AU$ 39.44M
Operating Cash Flow	AU$ 36.91M	AU$ 41.10M	AU$ 37.05M	AU$ 36.91M	AU$ 39.87M
Investing Cash Flow	AU$ -39.12M	AU$ -47.72M	AU$ -29.03M	AU$ -1.03M	AU$ -434.44K
Financing Cash Flow	AU$ -2.75M	AU$ -2.94M	AU$ -3.57M	AU$ -2.24M	AU$ -1.50M

Currency in AUD

Clinuvel Pharmaceuticals Earnings and Revenue History

Income Statement >

Clinuvel Pharmaceuticals Debt to Assets

Balance Sheet >

Clinuvel Pharmaceuticals Cash Flow

Cash Flow >

Clinuvel Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >